Latest / The Dales Report | Trade to Black
InMed Pharmaceuticals and Alzheimer’s Research
Join our Trade to Black Podcast with InMed Pharmaceuticals (NASDAQ: INM) CEO Eric Adams to learn how the company is pioneering Alzheimer’s treatment with innovative cannabinoid analogs. InMed focuses on cannabinoid analogs to treat Alzheimer’s, targeting multiple brain pathways for enhanced efficacy. InMed Pharmaceuticals is at the forefront of Alzheimer’s research, offering hope to millions and presenting a promising investment opportunity. Join TDR Co-Host Shadd Dales and Anthony Varrell as they discuss the potential and challenges in Alzheimer's research and how InMed Pharmaceuticals is…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.